Cargando…
Content Analysis of 2012-2019 FDA Warning Letters and Notices of Violations using the Economic, Clinical, and Humanistic Outcomes (ECHO) Model
OBJECTIVE: The study purpose was to critically review FDA-issued warning letters (WLs) and notice of violation (NOV) letters against drug companies’ from 2012-2019 for economic, clinical, and humanistic (ECHO) claims made in pharmaceutical promotional materials. Specific objectives were to assess th...
Autores principales: | Mohite, Namosha, Funtanilla, Vienica, Muzumdar, Jagannath, Park, Taehwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102978/ https://www.ncbi.nlm.nih.gov/pubmed/34007685 http://dx.doi.org/10.24926/iip.v12i1.3420 |
Ejemplares similares
-
PIN56 Content Analysis of FDA Warning Letters for Fraudulent COVID-19 Claims Using the Economic, Clinical, Humanistic Outcomes (ECHO) MODEL
por: Guo, J., et al.
Publicado: (2021) -
Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022
por: Dmour, Isra
Publicado: (2022) -
Impact of pharmacist services on economic, clinical, and humanistic outcome (ECHO) of South Asian patients: a systematic review
por: Shrestha, Sunil, et al.
Publicado: (2022) -
Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD)
por: Tsang, Yuen, et al.
Publicado: (2023) -
Unicorn Poo and Blessed Waters: COVID-19 Quackery and FDA Warning Letters
por: Bramstedt, Katrina A.
Publicado: (2020)